174 related articles for article (PubMed ID: 26685214)
1. Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
Li H; Wheeler S; Park Y; Ju Z; Thomas SM; Fichera M; Egloff AM; Lui VW; Duvvuri U; Bauman JE; Mills GB; Grandis JR
Mol Cancer Res; 2016 Mar; 14(3):278-86. PubMed ID: 26685214
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.
Lee RH; Roy R; Li H; Hechmer A; Zhu TR; Izgutdina A; Olshen AB; Johnson DE; Grandis JR
PLoS One; 2023; 18(3):e0282177. PubMed ID: 36857322
[TBL] [Abstract][Full Text] [Related]
3. Barriers to generating PDX models of HPV-related head and neck cancer.
Facompre ND; Sahu V; Montone KT; Harmeyer KM; Nakagawa H; Rustgi AK; Weinstein GS; Gimotty PA; Basu D
Laryngoscope; 2017 Dec; 127(12):2777-2783. PubMed ID: 28561270
[TBL] [Abstract][Full Text] [Related]
4. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
Kang HN; Kim JH; Park AY; Choi JW; Lim SM; Kim J; Shin EJ; Hong MH; Pyo KH; Yun MR; Kim DH; Lee H; Yoon SO; Kim DH; Park YM; Byeon HK; Jung I; Paik S; Koh YW; Cho BC; Kim HR
BMC Cancer; 2020 Apr; 20(1):316. PubMed ID: 32293356
[TBL] [Abstract][Full Text] [Related]
7. Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
Swick AD; Stein AP; McCulloch TM; Hartig GK; Ong IM; Sampene E; Prabakaran PJ; Liu CZ; Kimple RJ
Oral Oncol; 2017 Jan; 64():65-72. PubMed ID: 28024726
[TBL] [Abstract][Full Text] [Related]
8. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
9. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
11. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis.
Dowling P; Wormald R; Meleady P; Henry M; Curran A; Clynes M
J Proteomics; 2008 Jul; 71(2):168-75. PubMed ID: 18617144
[TBL] [Abstract][Full Text] [Related]
14. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of cancer--opportunities, challenges, and context.
Arnott D; Emmert-Buck MR
J Pathol; 2010 Sep; 222(1):16-20. PubMed ID: 20623483
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
[TBL] [Abstract][Full Text] [Related]
18. Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Yan L; Zhan C; Wu J; Wang S
Mol Med Rep; 2016 May; 13(5):4259-65. PubMed ID: 27035117
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
